Hinge Health, Inc. (HNGE) Stock: Price, Forecast & Analyst Target
Hinge Health, Inc. (HNGE) — MoonshotScore 97/100 (Exceptional band), calculated Nov 18, 2026. Price $108.10 (-5.61%), as of the Nov 19, 2026 trading session; market cap $8.79B. Expected results Feb 9, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 29.83× (cash as of Sep 30, 2026) · expected results Feb 9, 2027
Hinge Health, Inc. · HNGE · NYSE · Healthcare · Medical - Healthcare Information Services
Research dated 2026-09-13: Hinge Health sells specialized software for musculoskeletal care, spanning acute injuries, chronic pain and rehabilitation rather than operating as a general healthcare information vendor. The case depends on whether rising revenue, expanding operating profit and strong cash generation can persist while the company absorbs Cylinder without weakening its capital-light economics.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Hinge Health (HNGE)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, a strong balance sheet and elite growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.
- quarterly revenue $154M (Q3 FY2025, quarter ended Sep 2025)
- EPS beat 0 of the last 4 reports
- Altman Z 9.79 · Piotroski F 6
Helping: business quality, balance-sheet strength, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 95 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 97 | Exceptional | |
| 97 | Exceptional | |
| 97 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $108.10 | |
| Change on the day | -5.61% | |
| 52-week range | $30.08–$126.40 | |
| Market capitalisation | $8.79B | — |
| Price / earnings (trailing) | 55.00 | |
| Shares traded on the day | 1.69M | |
| Beta (volatility vs the S&P 500) | 1.36 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
We expect meaningful growth in revenue contribution to come in 2028, once we've had a full 2027 selling season with the integrated program. While I love where Migraine and GI are headed, I want to remind everyone that core MSK is still our largest revenue contributor by a wide margin, is growing robustly, and we expect it to remain that way for years to come.
Daniel Perez · Statement from
How to read these dates
A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for Hinge Health (HNGE): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 21, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 19, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Hinge Health (HNGE), and what does it report?
Short answer · as of
Hinge Health provides a software platform that manages musculoskeletal and joint-health needs, with administrative and operational support around the care offering.
Research dated 2026-09-13.
Demand therefore reflects use of a specialized care platform, not patient visits through a physical clinic network.
The accounts present the business as a consolidated reportable segment. Revenue, gross profit and operating expenses describe the platform as a whole, so the reported figures do not separate acute care, chronic pain, rehabilitation or administrative support into distinct business lines.
What do the latest results show for Hinge Health (HNGE)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $154M.
Research dated 2026-09-13.
The latest results extended a sequence of rising revenue and gross profit. Operating profit, net income and operating cash flow also strengthened, while the latest reported revenue exceeded the prevailing estimate and earnings came in slightly below its estimate.
The mechanism visible in the accounts is gross-profit expansion alongside controlled operating spending. Research and development and administrative costs increased, but the additional gross profit was sufficient to produce higher operating income. Management presented Cylinder as a future contribution rather than the explanation for the reported period.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $234.97M Sep 30, 2026
- Latest quarter · R&D
- $37.47M Sep 30, 2026
- Latest quarter · SG&A
- $116.53M Sep 30, 2026
- Latest quarter · FMP standardized operating result
- $50.33M Sep 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | $234.97M | $37.47M | $116.53M | $50.33M |
| Jun 30, 2026 | $212.82M | $34.06M | $109.45M | $40.44M |
| Mar 31, 2026 | $182.31M | $30.34M | $91.83M | $32.07M |
| Dec 31, 2025 | $170.73M | $32.76M | $83.50M | $27.26M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $234.97M Nov 2, 2026
- Latest report · revenue estimate
- $224.78M Nov 2, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 2, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 2, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 2, 2026 | $234.97M | $224.78M | $0.7100 | $0.5760 |
| Aug 4, 2026 | $212.82M | $201.46M | $0.5900 | $0.6150 |
| May 5, 2026 | $182.31M | $172.20M | $0.4500 | $0.3900 |
| Feb 10, 2026 | $170.73M | $156.66M | $0.4900 | $0.0400 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $154M | -$2M | -$0.02 (diluted) |
| Q4 FY2025 | $171M | $32M | $0.37 (diluted) |
| Q1 FY2026 | $182M | $35M | $0.41 (diluted) |
| Q2 FY2026 | $213M | $44M | $0.53 (diluted) |
What are the financial strengths and risks for Hinge Health (HNGE)?
Short answer
Cash and short-term investments were $294.65M at the Sep 30, 2026 balance-sheet date. Operating cash flow was $114.60M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Liquidity is a genuine strength: cash and investments substantially exceed debt, operating cash flow has remained positive across the reported sequence, and capital expenditure has been modest. The balance sheet therefore provides room to fund operations and strategic investment without relying heavily on borrowing.
Cylinder changes that cushion because management expects a material cash outlay and must still integrate and scale the acquired offering. The other pressure point is valuation: the market value stands far above net cash and trailing sales, so weaker growth or erosion in the platform's high gross margin could challenge the assumptions embedded in the shares.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
- Rich valuation — a P/E of 55.00 runs well above the Healthcare sector’s ~21.70x, leaving little room for a miss.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $114.60M Sep 30, 2026
- Previous quarter · operating cash flow
- $101.41M Jun 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Sep 30, 2026 | $114.60M | −$1.94M |
| Jun 30, 2026 | $101.41M | −$1.85M |
| Mar 31, 2026 | $43.08M | −$80,000 |
| Dec 31, 2025 | $63.90M | −$410,000 |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at Hinge Health (HNGE)?
Short answer · as of
The next earnings report is expected on Feb 9, 2027.
Research dated 2026-09-13.
Watch whether reported revenue continues to rise while gross margin, operating profit and operating cash flow hold their recent direction. Revenue growth without comparable cash conversion would weaken the evidence that the platform is scaling efficiently.
Cylinder deserves separate attention: closing cash, the initial revenue contribution and management's progress integrating the offering will show whether the acquisition broadens growth without consuming too much liquidity. The next earnings release also provides a direct check against expectations that currently assume continued revenue and earnings expansion.
What management is planning
What the records here don't tell us
- The newest quarter held here (Q3 FY2025) was filed Nov 7, 2025 — 12 months ago.
Checked against the records this page reads, on the dates shown above.
How does Hinge Health compare with its peers?
Short answer
Hinge Health's score ranks tied for 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Hinge Health's economics resemble specialized software more than a clinic network: gross margins are high, capital spending is light, and the product coordinates musculoskeletal care through a platform. Yet it is narrower than broad healthcare administration software because the offering is built around joint health, injuries, chronic pain and rehabilitation.
That combination concentrates the story. Investors do not receive separate segment disclosures for different care needs, so platform growth, gross-profit conversion and cash generation must carry the comparison with other digital-health businesses.
| Company | Price | Market value | Score |
|---|---|---|---|
| Hinge Health (HNGE) — this page | $108.10 | $8.79B | 97 |
| $26.17 Nov 19, 2026 | $8.13B | 97 5-pillar Nov 18, 2026 | |
| $102.10 Nov 19, 2026 | $6.68B | 96 5-pillar Nov 18, 2026 | |
| $29.61 Nov 19, 2026 | $5.28B | 95 5-pillar Nov 18, 2026 | |
| $35.45 Nov 19, 2026 | $2.61B | 95 5-pillar Nov 18, 2026 | |
| $97.38 Nov 19, 2026 | $8.05B | 90 5-pillar Nov 18, 2026 | |
| $64.02 Nov 19, 2026 | $12.7B | 87 5-pillar Nov 18, 2026 | |
| $24.69 Nov 19, 2026 | $3.15B | 79 5-pillar Nov 18, 2026 | |
| $81.89 Nov 19, 2026 | $37.0B | 74 5-pillar Nov 18, 2026 | |
| $310.90 Nov 19, 2026 | $8.69B | 60 5-pillar Nov 18, 2026 | |
| $57.38 Nov 19, 2026 | $7.55B | 38 5-pillar Nov 18, 2026 | |
| $44.63 Nov 19, 2026 | $3.92B | 35 5-pillar Nov 18, 2026 | |
| $59.61 Nov 19, 2026 | $10.9B | 33 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $80.00 – $140.00
- Consensus target
- $116.62
- Median target
- $112.00
Consensus record · Captured .
Measured against a quoted price of $108.10 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 11, 2026
- Transactions
- 226
- Identified insiders
- 8
- Purchases
- 0
- Sales
- 116
- Other transactions
- 110
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 84.5% Period end Sep 30, 2026
- Previous quarter · ownership
- 73.4% Prior to period end Sep 30, 2026
- Reporting holders
- 383 Period end Sep 30, 2026
- Previous quarter · holders
- 292 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 4,411,378 |
| Two Sigma Investments, LP | 2,559,509 |
| Vanguard Capital Management LLC | 2,513,093 |
| Vanguard Portfolio Management LLC | 2,492,160 |
| Morgan Stanley | 2,453,365 |
Tracked investors
Which of the 16 named investors we follow held HNGE in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported HNGE in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Hinge Health (HNGE)?
HNGE Healthcare Stock FAQ
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does the Hinge Health platform manage?
The platform covers musculoskeletal and joint health across acute injuries, persistent pain and post-operative rehabilitation, supported by administrative and operational services. Those activities are reported together rather than as separately disclosed segments.
Why does Cylinder matter to Hinge Health?
Cylinder is expected to add revenue after closing and to become more meaningful as Hinge Health integrates and scales the offering. It also requires a material cash payment, making post-close liquidity and execution important checks on the transaction.
Is Hinge Health producing cash as earnings improve?
Operating cash flow has been positive throughout the reported sequence and strengthened alongside recent profitability. Low capital spending means most of that operating cash generation has not been absorbed by physical investment, although the cash balance has moved unevenly over time.
What is creating Hinge Health's recent operating leverage?
Gross profit has risen faster than the operating expense base, allowing operating income to expand even as research, development and administrative spending increased. High gross margins and modest capital requirements reinforce the platform's software-like financial profile.
What is the HNGE stock price today?
The last price recorded for Hinge Health, Inc. (HNGE), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the HNGE price target?
The analyst consensus price target for Hinge Health, Inc. (HNGE), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 83 figures on this page — 2 from SEC filings and earnings calls, 75 from Financial Modeling Prep (FMP), 2 with no recorded source, 3 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com